Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study

It has been proposed that cytotoxic T-lymphocyte antigen 4 (CTLA-4) may attenuate the T-cell activation threshold, thereby decreasing the antitumor response and conferring susceptibility to hepatocellular carcinoma (HCC). In the present study, we selected CTLA-4 tagging single nucleotide polymorphis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Liu, Chao, Sun, Yuling, Chen, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709186/
https://www.ncbi.nlm.nih.gov/pubmed/31335675
http://dx.doi.org/10.1097/MD.0000000000016266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709186/
https://www.ncbi.nlm.nih.gov/pubmed/31335675
http://dx.doi.org/10.1097/MD.0000000000016266

Ejemplares similares